Research reveals EdU shows potential as a therapy for glioblastoma in diverse patient models, suggesting versatility in treatment options.
Figure S2: Features of glioblastoma models used to assess therapeutic potential of EdU. The features in red are less than desirable, blue are moderately desirable, and green are ideal. As such, the compounds were tested on multiple cell culture platforms to supplement the weaknesses of individual platforms.
No takes yet. Share an insight, caveat, or question.
Kaanoglu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: